Top of the Morning: Women and health - Challenges and opportunities
The desk argues that addressing the gender health gap presents both a significant opportunity and a critical risk factor affecting women's financial well-being, as outlined in the recent UBS Women and Health Report. The report highlights that women spend 25% more of their lives in poor health, a statistic that underscores a broader societal oversight that could have implications for economic productivity and healthcare investments. Per the full note, the growing startup ecosystem addressing these health disparities signals an emerging market segment ripe for investment. As institutional investors increasingly prioritize ESG and health equity in their portfolios, this sector could see enhanced flows, aligning well with sustainable finance initiatives.
What the desk is arguing
The desk contends that the underserved female health sector offers unique investment opportunities while highlighting systemic issues that could inhibit economic participation. The UBS report underscores that women, who on average live longer than men, face approximately nine years struggling with conditions that are often neglected, suggesting that addressing this gap could enhance labor force participation and overall economic output.
Moreover, as awareness of women’s health issues continues to escalate, this may catalyze a shift in healthcare investment priorities. The proliferation of startup ventures aimed at tackling these health conditions illustrates the potential for robust market growth, which may draw considerable investment interest.
Where it sits in our coverage
Our consensus target for relevant currency pairs is not available at present as no specific currencies have emerged from the internal coverage data. However, emerging investments in health-related sectors could shape future policy and market dynamics significantly.
How other firms see it
While specific forecasts from other firms are not available in the internal coverage data, it is worth noting that firms aligning with sustainable investment trends are likely to hold positive views on sectors influenced by health equity discussions. Firms prioritizing ESG principles appear attractive within this framework. Observations regarding broader economic indicators, such as healthcare spending growth and labor market trends, could intersect with this narrative in upcoming reports.
What the calendar says
There are currently no scheduled high-impact events that would directly impact this narrative in the short term.
Key takeaways
- 01The gender health gap results in women spending 25% more of their lives in poor health, significantly impacting financial well-being.
- 02Investment in health-focused startups addressing women's health issues is surging, indicating a ripe market for institutional investors.
- 03As ESG considerations rise, sectors focusing on health equity may attract additional investment flows, affecting financial dynamics.
- 04The current lack of consensus targets suggests that investment strategies will need to adapt as new insights emerge.
Market implications
Watch for developments in health policy reforms or significant investment announcements in women-focused health startups, as these could provide insights into shifting investment flows towards the sector. Institutional investors may increasingly seek exposure to these emerging opportunities reflecting broader societal needs.
Risks to this view
The primary risk to this narrative includes potential setbacks in policy changes related to health equity or a slowdown in the startup ecosystem's growth, which could derail investment flows. Additionally, macroeconomic factors affecting overall healthcare spending could significantly impact related sectors.
Hi everyone, Dan Cassidy here. Welcome back to Top of the Morning on the UBS Conversations podcast channel. For today, we will focus on the recently released UBS Women and Health Report, Challenges and Opportunities.
Joining me here for the conversation today, glad to welcome the publication's lead author, Mariana Mamou, Head of Advice Beyond Investing with the UBS Chief Investment Office at UBS Global Wealth Management. Now, the publication examines the gender health gap, what it is, how it affects women's lives and financial well-being, and CIO also highlights the rapid growth over the last few years in awareness around women's health and in the startup scene of companies trying to provide solutions. So, with that, Mariana, thank you very much for dropping by Top of the Morning today to spend some time with our listeners and our clients.
I believe this is the first time you are joining us here on Top of the Morning, so really nice to have you with us. Welcome. Thank you.
Very excited to be here. So, with that, I know there's a lot to talk about within the report, so let's dive right in. Perhaps begin by providing our listeners a bit of context.
Can you define for them what the gender health gap is and how it has impacted women? Yes, of course. Women live longer than men on average, but they spend 25% more of their lives in poor health.
That is approximately nine years of life spent struggling with conditions that are often invisible, untreated, or misunderstood. Often people consider female health to focus on conditions that are unique to women, and indeed, there are many conditions unique to women, such as menopause, endometriosis, women-specific oncology, and fertility. But there are also conditions that affect them disproportionately, such as autoimmune diseases, osteoporosis, or depression, as well as those that affect them differently, like cardiovascular diseases and diabetes.
For much of the 20th century, women were often left out of clinical trials, mainly due to concerns about pregnancy risks and hormonal cycles. This began to change in the early 90s when new policies required the inclusion of women and minorities in clinical trials. But while inclusion has improved, gaps remain.
In addition to underrepresentation in clinical trials, female health is underrepresented also in research. For example, in a report by Nature, only 5% of global research funding goes to female health, while just 1% goes to non-cancer, female-specific conditions. These data and research discrepancies result in big limitations in terms of what we know and understand about how best to treat women.
Sources & References
How we cover this story